iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model. ...Middle East

Secured the effectiveness confirming data of PHAGERIA® technology for colorectal cancer organoids The first target cancer type of PHAGERIA® technology is colorectal cancer (CRC) BOSTON and SEOUL, South Korea, April 3, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON",...

Hence then, the article about intron confirms cancer controlling effect of phageria drug candidate in the organoid model was published today ( Tuesday 04/04/2023 - 05:37 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model. )

Also on site :

• ‘AI Kid of India’ urges young people to embrace technology
• Evertune Releases Beginner's Guide to Generative Engine Optimization, Helping Enterprise Brands Increase AI Visibility
• LITEON Accelerates AI-RAN Commercialization By Integrating Its Open Radio Units with NVIDIA AI Aerial and Partner Solutions